R Squared Ltd Has $1.13 Million Stock Position in Kenvue Inc. $KVUE

R Squared Ltd lifted its position in shares of Kenvue Inc. (NYSE:KVUE) by 136.5% during the first quarter, Holdings Channel.com reports. The firm owned 65,589 shares of the company’s stock after purchasing an additional 37,859 shares during the period. Kenvue accounts for 0.6% of R Squared Ltd’s holdings, making the stock its 21st biggest position. R Squared Ltd’s holdings in Kenvue were worth $1,131,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in shares of Kenvue by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 234,951,484 shares of the company’s stock valued at $4,052,913,000 after purchasing an additional 1,604,040 shares in the last quarter. State Street Corp lifted its stake in Kenvue by 3.5% in the fourth quarter. State Street Corp now owns 118,865,134 shares of the company’s stock valued at $2,050,424,000 after purchasing an additional 4,063,257 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Kenvue by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 49,862,574 shares of the company’s stock valued at $856,778,000 after buying an additional 371,322 shares during the last quarter. Independent Franchise Partners LLP lifted its holdings in Kenvue by 56.3% during the fourth quarter. Independent Franchise Partners LLP now owns 48,146,476 shares of the company’s stock valued at $830,527,000 after purchasing an additional 17,343,785 shares during the last quarter. Finally, Norges Bank bought a new position in Kenvue in the 4th quarter worth approximately $756,862,000. Institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on KVUE shares. Barclays cut their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Tuesday, April 14th. Citigroup lowered their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Zacks Research raised Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, May 8th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Finally, UBS Group dropped their price target on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a report on Tuesday, April 7th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and a consensus price target of $19.33.

Insider Transactions at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of the business’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.59% of the stock is currently owned by insiders.

Kenvue Price Performance

Shares of NYSE:KVUE traded up $0.35 on Tuesday, reaching $19.91. The company’s stock had a trading volume of 4,881,569 shares, compared to its average volume of 30,253,311. The company has a market cap of $38.24 billion, a P/E ratio of 23.46, a PEG ratio of 1.50 and a beta of 0.47. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. The company has a 50-day simple moving average of $17.90 and a 200 day simple moving average of $17.73. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $22.87.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.24 earnings per share. As a group, equities research analysts anticipate that Kenvue Inc. will post 1.16 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, May 13th. This represents a $0.83 dividend on an annualized basis and a yield of 4.2%. Kenvue’s dividend payout ratio (DPR) is 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.